According to Lava Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 10.7191. At the end of 2023 the company had a P/S ratio of 6.14.
Year | P/S ratio | Change |
---|---|---|
2023 | 6.14 | |
2021 | 24.3 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |